Steul, Jean-Honoré
Abdel-Wahab, Mohamed
Stankowski, Tomasz
Haussig, Stephan
Woitek, Felix J.
Gasior, Tomasz
Crusius, Lisa
Knorr, Luise
Müller, Felicitas V.
Fritzsche, Dirk
Kiefer, Philipp
Kappert, Utz
Holzhey, David
Linke, Axel
Mangner, Norman http://orcid.org/0000-0003-0793-7923
Funding for this research was provided by:
Technische Universität Dresden
Article History
Received: 17 July 2023
Accepted: 16 November 2023
First Online: 11 December 2023
Declarations
:
: Norman Mangner has received personal fees from Edwards Lifesciences, Medtronic, B. Braun, Novartis, Sanofi Genzyme, AstraZeneca, Pfizer, Bayer, Abbott, Abiomed, and Boston Scientific outside the submitted work. Mohamed Abdel-Wahab reports that his hospital has received speaker’s honoraria and/or consultancy fees on his behalf from Abbott, Boston Scientific, and Medtronic. Stephan Haussig has received research grants to the institution from Edwards Lifesciences, and personal fees from Edwards Lifesciences, Abbott Vascular, and Boston Scientific, outside the submitted work. Felix J. Woitek reports personal fees from Abbott, Abiomed, Boston Scientific, Neovasc, Asahi, Biotronik, and Corvia Medical, outside the submitted work. Tomasz Gasior is currently an employee of Boehringer Ingelheim. Axel Linke has received personal fees from Medtronic, Abbott, Edwards Lifesciences, Boston Scientific, AstraZeneca, Novartis, Pfizer, Abiomed, Bayer, and Boehringer outside the submitted work. The other authors have no conflicts of interest to declare.